View Post

Advancing Care in Metastatic Breast Cancer

In In The News by Barbara Jacoby

By: Dietmar Berger, Global Head of Development, Sanofi From: onclive.com As the most commonly diagnosed type of cancer, the devastating effects of breast cancer continue to impact families around the world.1 It’s the fifth most frequent cause of cancer deaths globally, resulting in an estimated 685,000 deaths in 2020 alone, and a physical and emotional burden for patients and their …

View Post

Shining a light on gaps in breast cancer care: A call for increased equity

In In The News by Barbara Jacoby

By: Mark Straley From: medcitynews.com As an industry, we should be proud of all that we have accomplished in making precision medicine a reality, whether it has been through advances in screening, drug development, diagnostics, or delivery. However, our work has just begun. When we look back on the advent of precision medicine, the health care community will reflect on …

View Post

“Stage Zero” Breast Cancer: What’s the Optimal Treatment for DCIS?

In In The News by Barbara Jacoby

From: cuimc.columbia.edu Before the advent of routine mammography, DCIS (ductal carcinoma in situ) was rarely detected. But today, DCIS accounts for 20% of breast cancer diagnoses and would be the fifth most common cancer in women if classified independently. Often called “stage zero breast cancer,” DCIS growths are confined to the inside of the breast’s milk ducts, and many never …

View Post

A pill for breast cancer? There’s one for early-stage patients with aggressive cases — and it works

In In The News by Barbara Jacoby

By: Peter Loftus, Wall Street Journal From: geneticliteracyproject.org A drug sold by AstraZeneca and Merck & Co. reduced the recurrence of breast cancer in women with an early but aggressive form of the disease, a long-running international study found. The finding, which on [June 3] was published online by the New England Journal of Medicine and released at a major …

View Post

Black and White Women Have Same Mutations Linked to Breast Cancer Risk

In In The News by Barbara Jacoby

From: pennmedicine.org Penn study underscores importance of addressing genetic testing disparity in Black women The prevalence of genetic mutations associated with breast cancer in Black and white women is the same, according to a new JAMA Oncology study of nearly 30,000 patients led by researchers in the Basser Center for BRCA at the Abramson Cancer Center. About five percent of …

View Post

Research From Roswell Park and Kaiser Permanente Supports Vitamin D Supplementation for Breast Cancer Patients

In In The News by Barbara Jacoby

Source: Roswell Park From: roswellpark.org Benefits may be most pronounced for Black women and patients diagnosed with higher-stage disease The joint Roswell Park Comprehensive Cancer Center/Kaiser Permanente Northern California team behind a new study to be highlighted at the American Society of Clinical Oncology (ASCO) 2021 virtual annual meeting has found that sufficient vitamin D levels at the time of …

View Post

Heart-protecting drugs likely unnecessary for many breast cancer patients

In In The News by Barbara Jacoby

Source: American College of Cardiology From: eurekalert.org Patients at low risk for heart disease show no long-term benefit from cardioprotective drugs Taking medications to protect the heart from damage associated with adjuvant breast cancer therapy–medications that are administered in addition to surgery to remove a tumor–did not significantly improve markers of heart health two years after breast cancer treatment, according …

View Post

Breast cancer patients embrace integrative health during treatment

In In The News by Barbara Jacoby

Source: The Reis Group From: eurekalert.org National survey finds oncologists underestimate patient use of complementary and lifestyle therapies Nearly three-quarters of breast cancer patients (73%) report using at least one type of complementary medicine after cancer diagnosis, while oncologists believe that less than half (43%) of patients are using these approaches during cancer care. These and other findings from a …